Tag: CIRSE 2019

CIRSE 2019: New data show high chronic outward force causes significantly...

Twelve-month results of the BIOFLEX COF trial have demonstrated that the implantation of stents with low chronic outward force (COF) was associated with less...

CIRSE 2019: New Cook Medical paclitaxel data confirm safety of Zilver...

New data on the use of Zilver PTX, Cook Medical’s paclitaxel-coated stent for peripheral arterial disease (PAD), confirm the safety of the device. These...

TINTIN trial shows “impressive” results at six months

The six-month results of TINTIN (Treatment with the lumINor DCB and The IVolutioN self-expanding stent) trial have been revealed at the annual meeting of the Cardiovascular and...
AV access

CIRSE 2019: IN.PACT AV access trial meets primary safety and effectiveness...

Medtronic has announced the first-ever results from the IN.PACT AV access clinical study comparing the investigational IN.PACT AV drug-coated balloon (DCB) to percutaneous transluminal...